Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Bullous pemphigoid in a patient with multiple sclerosis being treated with human immunoglobulin.
Progressive outer retinal necrosis in a multiple sclerosis patient on natalizumab.
Detecting cortical lesions in multiple sclerosis at 7 T using white matter signal attenuation.
Transcriptomics: mRNA and alternative splicing.
Metabolomics of cerebrospinal fluid reveals changes in the central nervous system metabolism in a rat model of multiple sclerosis.
Santhera receives first product approval: Health Canada approves Catena® for treatment of Friedreich's ataxia
Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders: Report of the Guideline Development Subcommittee of the American Academy of Neurology.
Ustekinumab induction and maintenance therapy in refractory Crohn's disease.
Drugs to be Discontinued
Medical marijuana: clearing away the smoke.
Phase IV Study Reports Multiple Sclerosis Success with Teriflunomide
Topical Application of Fingolimod Perturbs Cutaneous Inflammation.
Use of the multiple sclerosis functional composite as an outcome measure in a phase 3 clinical trial.
Food and Drug Administration briefing document for ofatumumab
Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis.
GLACIER: An open-label, randomized, multicenter study to assess the safety and tolerability of glatiramer acetate 40mg three-times weekly versus 20mg daily in patients with relapsing-remitting multiple sclerosis.
Enhancement of endocannabinoid signaling by fatty acid amide hydrolase inhibition: a neuroprotective therapeutic modality.
Genzyme’s Lemtrada™ approved in Canada for treatment of multiple sclerosis
A randomized placebo-controlled trial of idebenone in Leber's hereditary optic neuropathy.
Modulation of IL-2Rα with daclizumab for treatment of multiple sclerosis.
Patient page. Multiple sclerosis and vitamin D.
Exogenous schwann cells migrate, remyelinate and promote clinical recovery in experimental auto-immune encephalomyelitis.
Metabolomic profiling in multiple sclerosis: insights into biomarkers and pathogenesis.
Treatment selection and experience in multiple sclerosis: survey of neurologists.
Abnormalities of Motor Imagery and Relationship With Depressive Symptoms in Mildly Disabling Relapsing-Remitting Multiple Sclerosis.

Pages